CODX
Co-diagnostics·NASDAQ
--
--(--)
--
--(--)
CODX fundamentals
Co-diagnostics (CODX) Revenue Breakdown: Q3 2025 Business & Regional Performance
Co-diagnostics (CODX) reported total revenue of 145.38K USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 94.06% of total revenue. Explore Co-diagnostics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Co-diagnostics (CODX) reported total revenue of 145.38K USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 94.06% of total revenue. Explore Co-diagnostics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is Co-diagnostics's gross profit margin?What is Co-diagnostics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Co-diagnostics year over year?What does Co-diagnostics do and what are its main business segments?What guidance did Co-diagnostics's management provide for the next earnings period?What factors drove the changes in Co-diagnostics's revenue and profit?What were the key takeaways from Co-diagnostics’s earnings call?Did Co-diagnostics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
